Strong equity issuance has continued into late 2026, with U.S. companies raising over $146 billion year-to-date through IPOs amid elevated valuations for AI-related firms, though a handful of mega-deals have faced delays. Rising 10-year Treasury yields near 5.3% and renewed Federal Reserve rate hikes have pressured timing for some candidates, while recent performance of listings like SK Hynix and smaller biotechs supports broader market receptivity. A sizable pipeline of filings remains active, with names such as Anthropic targeting possible completion before year-end and others like OpenAI leaning toward 2027. Key near-term catalysts include Q4 market stability, midterm election outcomes, and any shifts in monetary policy expectations that could alter issuance windows before December 31.